Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Assets Average (2021 - 2025)

Historic Assets Average for RxSight (RXST) over the last 5 years, with Q3 2025 value amounting to $308.8 million.

  • RxSight's Assets Average rose 25.55% to $308.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $308.8 million, marking a year-over-year increase of 25.55%. This contributed to the annual value of $250.6 million for FY2024, which is 5061.37% up from last year.
  • According to the latest figures from Q3 2025, RxSight's Assets Average is $308.8 million, which was up 25.55% from $311.0 million recorded in Q2 2025.
  • RxSight's Assets Average's 5-year high stood at $315.8 million during Q1 2025, with a 5-year trough of $149.3 million in Q3 2021.
  • In the last 5 years, RxSight's Assets Average had a median value of $188.6 million in 2023 and averaged $220.6 million.
  • Its Assets Average has fluctuated over the past 5 years, first crashed by 2284.91% in 2022, then skyrocketed by 7270.47% in 2025.
  • Over the past 5 years, RxSight's Assets Average (Quarter) stood at $198.2 million in 2021, then fell by 22.85% to $152.9 million in 2022, then grew by 19.14% to $182.2 million in 2023, then surged by 72.62% to $314.5 million in 2024, then fell by 1.83% to $308.8 million in 2025.
  • Its Assets Average was $308.8 million in Q3 2025, compared to $311.0 million in Q2 2025 and $315.8 million in Q1 2025.